Cefadroxil
Sponsors
University Of Cologne, Karlstad University, National University Hospital, Singapore, Genuine Research Center, Egypt, AbbVie
Conditions
Autoimmune DiseasesBacterial InfectionsChronic Kidney DiseasesDiabetesHealthyInfections Joint ProstheticInflammatory DiseaseJoint Infection
Phase 1
A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)
CompletedNCT02479867
Start: 2014-03-31End: 2014-04-30Updated: 2015-06-24
Cefadroxil and Cephalexin Drug Levels and Dosing in Pediatric Musculoskeletal Infections
CompletedNCT03802552
Start: 2019-05-01End: 2021-04-30Updated: 2021-06-02
Phase 2
Phase 3
Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA
CompletedNCT02814916
Start: 2017-03-30End: 2024-01-01Updated: 2024-09-19
Or v IV Antibiotics for Infection
NCT04723940
Start: 2021-01-25End: 2023-01-25Target: 308Updated: 2021-01-26
Phase 4
Antibiotic Prophylaxis in High-Risk Arthroplasty Patients
Enrolling by invitationNCT04297592
Start: 2020-06-11End: 2028-01-01Target: 4618Updated: 2026-07-06
Early switch to oral antibiotic therapy in vertebral osteomyelitis: a multicentre, open-label, randomised, active control, parallel group, non-inferiority trial (sWITCH-VO)
Not yet recruitingCTIS2026-526270-17-00
Target: 280Updated: 2026-07-09